Skip to content

INFI-DO-SE CLINIQUE MOBILE

Active Private limited companyfounded 2021active for 5 yearsAntwerpsesteenweg 34, 1000 BrusselsKBO/BCE: BE 0768.533.176

Lifetime

4 annual accounts with figures on one time axis
peak €88,730 (2022)
€41,527▲ €65,639
lowest -€40,788 (2024)
€2,028▲ €42,816
peak €30,319 (2022)
-€8,611▲ €2,028
€68,415▲ 42.1%
Board1 name since 2021
Documentsfilings and deeds
01-09-202632 days late
2025micro format
Gross margin from -€24,112 to €41,527Back to profit: €2,028Equity from -€10,639 to -€8,611Debts from €48,137 to €68,4151 establishment registeredCash from €2,007 to €321

Key points

from the 2025 annual accounts

Equity

-€8,611
2022202320242025

Debts exceed assets in financial year 2025.

Turnover

≈ €130,000 estimated

The micro format states no turnover.

Debts

€68,415 114% of the balance sheet
Suppliers 17%Taxes and wages 83%

Staff

2 employees on 31-12-2025
222022532025

In 2025, 5 people joined and 3 left.

Filings

4 annual accounts 3 late
AprilJune31 JulyOctober2022202320242025

The 2024 accounts came latest: 33 days after the end of the period.

Position in the sector

-14.4%

Lower solvency than 95% of companies in human health. Sector median 63.0% · 20,760 companies.

Checked score

53
Fair
Financially stronger than 18% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%

Negative equity caps the score at 59.

Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,183 companies (NACE 86, micro).

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 1.0% 01-2025: 0.9%▼ -0.1 percentage points vs 12-2024 02-2025: 0.9%● unchanged vs 01-2025 03-2025: 1.0%▲ +0.1 percentage points vs 02-2025 04-2025: 1.1%▲ +0.1 percentage points vs 03-2025 05-2025: 1.2%▲ +0.1 percentage points vs 04-2025 06-2025: 1.2%● unchanged vs 05-2025 07-2025: 1.2%● unchanged vs 06-2025 08-2025: 1.8%▲ +0.6 percentage points vs 07-2025 09-2025: 2.4%▲ +0.6 percentage points vs 08-2025highest value 10-2025: 1.3%▼ -1.1 percentage points vs 09-2025 11-2025: 1.3%● unchanged vs 10-2025 12-2025: 0.6%▼ -0.7 percentage points vs 11-2025lowest value 01-2026: 0.6%● unchanged vs 12-2025lowest value 02-2026: 0.6%● unchanged vs 01-2026lowest value 03-2026: 0.7%▲ +0.1 percentage points vs 02-2026 04-2026: 0.7%● unchanged vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 1.1%▲ +0.4 percentage points vs 07-2026 09-2026: 1.3%▲ +0.2 percentage points vs 08-2026 10-2026: 0.6%▼ -0.7 percentage points vs 09-2026 11-2026: 0.6%● unchanged vs 10-2026

Financial strength
Weak

11+11equity -14.4% of total assets
1-6short-term debt 114.4% · cash 0.5%
46+46return on assets 3.4%

Score breakdown

raises risk
Capped at 59: negative equity
Liquidity: current ratio 0.78, cash €321, halved
Negative equity -€8,611
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €59,804
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 2% of them on solvency, 0% on liquidity, 7% on profitability and 63% on growth.

The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 906 companies had the same profile as INFI-DO-SE CLINIQUE MOBILE has now. Each dot stands for 3 companies, two years later.

89.4%
were still trading
4.1%
stopped another way
6.1%
went bankrupt
  • Micro
  • 5 to 10 years old
  • negative equity
  • a profit under 5% of the balance sheet

Another 0.4% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of INFI-DO-SE CLINIQUE MOBILE itself is lower: 0.6% within 12 months. It rests on far more data about INFI-DO-SE CLINIQUE MOBILE than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 906 companies, not a prediction for INFI-DO-SE CLINIQUE MOBILE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

No credit on open account

Liquidity is insufficient, with a current ratio of 0.78 (0.69 in 2024), below 1. Short-term debt is 114.4% and cash 0.5% of total assets. Equity is negative.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 0.78, cash €321, halved
NBB · annual accounts
raises risk · Negative equity -€8,611
NBB · annual accounts
lowers risk · Size: total assets €59,804
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20760 sector peers (2025).
NBB · sector comparison
Position among 20760 sector peers
Solvency
better than 5%
← weakest strongest →
raises risk · 2025 accounts filed 32 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-09-2026, 32 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filings
Deviation from the deadline
2025
32 days late
2024
33 days late
2023
15 days early
2022
12 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 16 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 August (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

  • NTUMBA KALONJI Nouchka 100 sharesdeed of 21-05-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0768533176
New establishment in Ixelles Afro Délices, Sint-Bonifaasstraat 29
Registered office moved within Brussels New registered office: Chaussée d'Anvers, 34-1000 Bruxelles · Previous registered office: rue des six jetons, 71-1000 Bruxelles · General meeting of 20-10-2023 · Gazette deed
Incorporation Founding capital of €7,500, 100 shares, €5,000 paid up · Founder: NTUMBA KALONJI Nouchka · Appointment: NTUMBA KALONJI Nouchka (director) · published on 21-05-2021 · Gazette deed
All 11 events

Comparable companies

same main activity, similar in size and age
Company
INFI-DO-SE CLINIQUE MOBILE Brussels €59,804 €41,527 -14.4% -
Claudia Dirnu Lessines €61,917 €45,186 4.4% -
L1 Sint-Niklaas €58,668 €43,588 6.4% -
SimplyCare Menen €64,082 €38,204 56.9% -
EL NANI Veurne €55,298 €38,043 66.3% -
Bianca Dupon Thuisverpleging Beveren-Kruibeke-Zwijndrecht €71,117 €43,098 85.1% -
CARING WITH JOY Schaerbeek €49,671 €30,917 31.4% -

These companies have the same main activity as INFI-DO-SE CLINIQUE MOBILE: nursing and midwifery (NACE 86940). They are comparable in size and age: total assets between €49,700 and €71,100, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 19-05-2021Normal situation
Activity
Nursing and midwiferyNACE 86940and 2 others
Establishment units
2.317.287.6361000 Brussels, since 19-05-2021
2.371.823.0161050 Ixelles, since 15-04-2025
Financial year end
31 December
Peppol
Reachable since 03-02-2026
Company details

Annual accounts 2025

€59,804▲ 59.5%
Employeeson 31-12-2025
2
Filing
Filed on 01-09-2026
Financials

Insights on INFI-DO-SE CLINIQUE MOBILE

INFI-DO-SE CLINIQUE MOBILE files the micro format. That format states no turnover. The gross margin fell from €88,730 in 2022 to €41,527 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about INFI-DO-SE CLINIQUE MOBILE

What is the company number of INFI-DO-SE CLINIQUE MOBILE?
The company number of INFI-DO-SE CLINIQUE MOBILE is 0768.533.176. The VAT number is the same number with BE in front: BE 0768.533.176.
Where is INFI-DO-SE CLINIQUE MOBILE based?
The registered office is at Antwerpsesteenweg 34, 1000 Brussels.Company details
What does INFI-DO-SE CLINIQUE MOBILE do?
According to the KBO register, the main activity is nursing and midwifery (NACE 86940).
What is the legal form of INFI-DO-SE CLINIQUE MOBILE?
INFI-DO-SE CLINIQUE MOBILE is a private limited company (BV).
When was INFI-DO-SE CLINIQUE MOBILE founded?
INFI-DO-SE CLINIQUE MOBILE was founded on 19-05-2021.
Is INFI-DO-SE CLINIQUE MOBILE still active?
Yes, INFI-DO-SE CLINIQUE MOBILE is an active enterprise in the KBO register.
How many employees does INFI-DO-SE CLINIQUE MOBILE have?
INFI-DO-SE CLINIQUE MOBILE had an average of 1.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of INFI-DO-SE CLINIQUE MOBILE?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €41,527 and 34 comparable companies (NACE 869). It probably lies between €96,000 and €180,000.
Is INFI-DO-SE CLINIQUE MOBILE profitable?
In financial year 2025, INFI-DO-SE CLINIQUE MOBILE made a profit of €2,028.
Where can I find the annual accounts of INFI-DO-SE CLINIQUE MOBILE?
INFI-DO-SE CLINIQUE MOBILE filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of INFI-DO-SE CLINIQUE MOBILE due?
INFI-DO-SE CLINIQUE MOBILE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.